Oncology Pharmacists Connect: 2025 agenda features a comprehensive lineup of sessions designed to enhance your knowledge and practice in oncology pharmacy. Building on the success of 2024, the 2025 event will include:
- Expert-Led Discussions: Engage with leading experts in oncology pharmacy through panel discussions and Q&A sessions that will provide deeper insights into clinical, operational, and financial analysis of trial updates and patient care strategies, directly informed by the 2025 ASCO Annual Meeting.
- Networking Opportunities: Connect with peers, researchers, and industry leaders to exchange ideas, discuss challenges, and forge collaborations that will advance your practice in the field of oncology pharmacy.
New Ways to Connect in 2025:
- Poster Session: Showcase your clinical and practice management research or explore the latest advancements in oncology pharmacy during the networking reception. See poster session tab for more details on submitting an abstract.
- Interactive Workshops: Enhance your professional development and problem-solving skills with actionable strategies to resolve challenges in oncology pharmacy.
Overview:
The complexity of new regimens and the need for coordination of care across practice and pharmacy settings has reinforced and expanded the roles of oncology pharmacists. This conference is designed for oncology pharmacists to meet as a larger ecosystem of pharmacists working together to identify and develop solutions for responding clinically and operationally to rapidly evolving evidence reported at the 2025 ASCO Annual Meeting. The program agenda facilitates bringing pharmacists focused on cancer care from multiple types of practice settings together to discuss recently presented data, identify resources needed to successfully implement new therapies and make formulary decisions, examine challenges, and brainstorm solutions to meet organizational demands while improving patient outcomes. The core meeting will be composed of accredited continuing education sessions, highlighting the most impactful ASCO abstracts from each disease state delivered as panel discussions to enable debate, discussion, and collaborative peer-exchange.
Core sessions include: hematologic malignancies, multiple myeloma, leukemia/lymphoma, genitourinary, gastrointestinal, cutaneous, thoracic, and breast cancers as well as delivery and quality of oncology care.
- Analyze recent clinical updates on novel and emerging pharmacotherapeutic approaches for solid and hematologic malignancies presented at the 2025 American Society of Clinical Oncology Annual Meeting.
- Explain the impact of recent evidence to multiple disease treatment paradigms and challenges to implementation of evolving therapies.
- Apply operational and managed care considerations for the evaluation and integration of changes through formulary decisions, pathways, and resource allocation.
Become part of the oncology pharmacy thread that connects people together to fight cancer. Join us at OPC this summer and continue building your oncology pharmacy connections!
